Published in Ann Intern Med on November 01, 2005
Infectious disease transmission during organ and tissue transplantation. Emerg Infect Dis (2012) 1.45
Risk factors in the development of stem cell therapy. J Transl Med (2011) 1.38
Zika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in Tears. Cell Rep (2016) 1.25
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep (2013) 1.17
Adverse reactions and events related to musculoskeletal allografts: reviewed by the World Health Organisation Project NOTIFY. Int Orthop (2011) 1.08
Seronegative hepatitis C virus infection. Arch Immunol Ther Exp (Warsz) (2013) 0.89
Virus NAT for HIV, HBV, and HCV in Post-Mortal Blood Specimens over 48 h after Death of Infected Patients - First Results. Transfus Med Hemother (2012) 0.88
Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples. Transfus Med Hemother (2012) 0.86
Coding and traceability for cells, tissues and organs for transplantation. Cell Tissue Bank (2010) 0.82
Traceability. Cell Tissue Bank (2010) 0.75
Viral Inactivation of Human Osteochondral Grafts with Methylene Blue and Light. Cartilage (2014) 0.75
HCV RNA Testing of Plasma Samples from Cornea Donors: Suitability of Plasma Samples Stored at 4 °C for up to 8 Days. Transfus Med Hemother (2016) 0.75
Use of Hepatitis C-Positive Donor Livers in Liver Transplantation. Curr Hepatol Rep (2017) 0.75
Risk of virus transmission through femoral head allografts: A Belgian appraisal. J Clin Orthop Trauma (2013) 0.75
Hepatitis B transmission by cell and tissue allografts: how safe is safe enough? World J Gastroenterol (2014) 0.75
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep (2005) 5.70
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep (2006) 5.63
FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis (2004) 5.53
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis (2007) 5.36
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA (2005) 5.29
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Ebola 2014--new challenges, new global response and responsibility. N Engl J Med (2014) 5.23
Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev (2006) 5.13
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis (2008) 4.91
Health care-associated invasive MRSA infections, 2005-2008. JAMA (2010) 4.79
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med (2007) 4.69
A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol (2005) 4.48
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis (2002) 4.08
An outbreak of hepatitis A associated with green onions. N Engl J Med (2005) 3.89
Salmonellosis outcomes differ substantially by serotype. J Infect Dis (2008) 3.77
Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 3.77
Vascular access hemorrhages contribute to deaths among hemodialysis patients. Kidney Int (2012) 3.40
Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16
Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med (2010) 3.13
Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis (2009) 3.09
Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA (2004) 3.05
Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis (2008) 2.95
Chickenpox outbreak in a highly vaccinated school population. Pediatrics (2004) 2.95
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA (2006) 2.93
Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis (2007) 2.80
Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology (2004) 2.78
Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology (2008) 2.66
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis (2010) 2.62
Incidence of hepatitis A in the United States in the era of vaccination. JAMA (2005) 2.42
Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep (2010) 2.31
Surveillance for foodborne disease outbreaks - United States, 1998-2008. MMWR Surveill Summ (2013) 2.27
Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med (2009) 2.25
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology (2005) 2.24
Consumer attitudes and use of antibiotics. Emerg Infect Dis (2003) 2.20
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. J Clin Oncol (2011) 2.14
Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11
Hepatitis B virus transmissions associated with a portable dental clinic, West Virginia, 2009. J Am Dent Assoc (2013) 2.07
Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis (2002) 2.06
Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis (2011) 1.91
Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis (2005) 1.90
Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerg Infect Dis (2002) 1.89
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis (2008) 1.86
Characteristics and proportion of dying Oregonians who personally consider physician-assisted suicide. J Clin Ethics (2004) 1.85
Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development. J Cell Sci (2003) 1.78
Hepatitis A in the era of vaccination. Epidemiol Rev (2006) 1.75
Chicken consumption is a newly identified risk factor for sporadic Salmonella enterica serotype Enteritidis infections in the United States: a case-control study in FoodNet sites. Clin Infect Dis (2004) 1.73
Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med (2006) 1.67
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis (2009) 1.66
A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis (2009) 1.66
Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012. Clin Infect Dis (2014) 1.65
Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health (2002) 1.61
Hepatitis C virus infections from unsafe injection practices at an endoscopy clinic in Las Vegas, Nevada, 2007-2008. Clin Infect Dis (2010) 1.57
Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis (2008) 1.57
Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clin Infect Dis (2004) 1.55
Chronic liver disease mortality in the United States, 1990-1998. Hepatology (2004) 1.55
Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis. J Am Acad Dermatol (2007) 1.55
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis (2008) 1.55
Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. Am J Infect Control (2003) 1.53
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis (2002) 1.51
Population-based surveillance for acute liver failure. Am J Gastroenterol (2007) 1.51
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend (2007) 1.50
Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. Infect Control Hosp Epidemiol (2011) 1.48
Antimicrobial use in outpatient hemodialysis units. Infect Control Hosp Epidemiol (2013) 1.46
Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009. Infect Control Hosp Epidemiol (2012) 1.46
Incidence and trends of infection with pathogens transmitted commonly through food--Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2013. MMWR Morb Mortal Wkly Rep (2014) 1.45
Comparison of survey methods in norovirus outbreak investigation, Oregon, USA, 2009. Emerg Infect Dis (2010) 1.41
Legalized physician-assisted suicide in Oregon, 2001. N Engl J Med (2002) 1.39
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial. Cancer (2012) 1.36
2008 outbreak of Salmonella Saintpaul infections associated with raw produce. N Engl J Med (2011) 1.36
Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Arch Intern Med (2011) 1.35
Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis (2002) 1.34
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS (2010) 1.32
Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib. Cancer (2012) 1.31
Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics (2002) 1.30
End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods (2008) 1.28
Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility. Am J Public Health (2005) 1.28
Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Emerg Infect Dis (2002) 1.27
A phase I dose-escalation study of Tivantinib (ARQ 197) in adult patients with metastatic solid tumors. Clin Cancer Res (2011) 1.27
Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol (2009) 1.25
Preliminary incidence and trends of infection with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2014. MMWR Morb Mortal Wkly Rep (2015) 1.24
Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J (2008) 1.20
Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J (2005) 1.19
Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. Hepatology (2008) 1.17